Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 14 December 2007:
Vol. 318. no. 5857, p. 1722
DOI: 10.1126/science.1149590
Prev | Table of Contents | Next

Technical Comments

Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells"

James A. Kennedy,1,2 Frédéric Barabé,3,4,5 Armando G. Poeppl,1 Jean C. Y. Wang,1,6,7 John E. Dick1,2*

Kelly et al. (Brevia, 20 July 2007, p. 337) questioned xenotransplant experiments supporting the cancer stem cell (CSC) hypothesis because they found a high frequency of leukemia-initiating cells (L-IC) in some transgenic mouse models. However, the CSC hypothesis depends on prospective purification of cells with tumor-initiating capacity, irrespective of frequency. Moreover, we found similar L-IC frequencies in genetically comparable leukemias using syngeneic or xenogeneic models.

1 Division of Cell and Molecular Biology, University Health Network, Toronto, Canada.
2 Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada.
3 Department of Medicine, Laval University, Québec, Canada.
4 Department of Hematology, Enfant-Jesus Hospital, Québec, Canada.
5 Research Center in Infectious Diseases, Centre Hospitalier Universìtaire de Québec/Centre Hospitalier de l'Université Laval, Québec, Canada.
6 Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Canada.
7 Department of Medicine, University of Toronto, Toronto, Canada.

* To whom correspondence should be addressed. E-mail: jdick{at}uhnres.utoronto.ca

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)